Shanghai Euhearing Therapeutics

Euhearing Therapeutics is a Shanghai-based biotechnology company specializing in the development of innovative therapies for hearing loss and inner ear disorders. Founded by leading experts in otolaryngology from Fudan University, the company focuses on gene therapy and small molecule approaches to address unmet medical needs in sensorineural hearing loss. Their lead program, EUH-001, is an AAV-based gene therapy targeting OTOF-related deafness, which has demonstrated clinical efficacy in restoring hearing in pediatric patients. The company leverages a proprietary delivery platform designed to target the complex anatomy of the inner ear. Euhearing aims to become a global leader in regenerative medicine for sensory organs through precision genetic interventions.